НАСЛЕДСТВЕННЫЕ БОЛЕЗНИ
ТЕРАПИЯ
А
LEBER CONGENITAL AMAUROSIS
GENE THERAPY
◊
Recombinant adeno-associated viruses (rAAVs)
◊
Genetic treatment for blindness
◊
Leber Congenital Amaurosis Clinical Trials
LEUKEMIA
CAR-T THERAPY
◊
Leukemia: CAR-T gene therapy
◊
CRISPR-directed gene editing as a therapeutic strategy for leukemia and beyond
◊
A toolmaker’s perspective on CRISPR-directed gene editing as a therapeutic strategy for leukemia and beyond
LIMB GIRDLE MUSCULAR DYSTROPHY 2B
GENE THERAPY
◊
Secreted acid sphingomyelinase as a potential gene therapy for limb girdle muscular dystrophy 2B
LIMBAL STEM CELL DEFICIENCY (LSCD)
THERAPY
◊
The Multifold Etiologies of Limbal Stem Cell Deficiency: Treatment Options for Limbal Stem Cell Deficiency
LIPIDEMIAS
GENE EDITING
◊
Gene editing for dyslipidemias: New tools to “cut” lipids
LIPID NANOPARTICLES
CRISPR–Cas GENE EDITING
◊
Membrane-destabilizing ionizable phospholipids and CRISPR–Cas gene editing
LIVER DISEASES
THERAPY
◊
Human antigen R: A potential therapeutic target for liver diseases
◊
Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytes
GENE THERAPY
◊
Novel vectors and approaches for gene therapy in liver diseases
◊
In vivo Gene Therapy to the Liver and Nervous System: Promises and Challenges
◊
Liver-directed gene therapy for inherited metabolic diseases
LONG-TERM EXPRESSION OF BIOTHERAPEUTICS
GENE THERAPY
◊
gene therapy to achieve long-term continuous or controllable expression of biotherapeutics
LUNG DISEASES
GENE THERAPY
◊
New Directions in Pulmonary Gene Therapy
LIVER FIBROSIS
THERAPY
◊
Overexpression of Mitofusin-2 in Hepatic Stellate Cells Ameliorates Liver Fibrosis
LUNG ADENOCARCINOMA
IMMUNE CHECKPOINT BLOCKADE mRNA
◊
Lung adenocarcinoma immune checkpoint blockade mRNA expression B cells
LUNG DISEASES
GENE EDITING
◊
In Utero Gene Editing for Inherited Lung Diseases
LUNG FIBROSIS
DRUG THERAPY
◊
Metformin reverses established lung fibrosis in a bleomycin model.
LUNG TRANSPLANTATION
GENE THERAPY TRANSPLANT
◊
Creating superior lungs for transplantation with next-generation gene therapy during ex vivo lung perfusion
LYMPHEDEMA
THERAPY
◊
Immediate lymphatic reconstruction for the prevention of breast cancer-related lymphedema
LYMPHATIC MALFORMATIONS
THERAPY
◊
Genetic and Molecular Determinants of Lymphatic Malformations: Potential Targets for Therapy
LYSOSOMAL STORAGE DISORDER
CELL THERAPY
◊
Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells
GENETHERAPY
◊
Effects of gene therapy on cardiovascular symptoms
◊
Molecular Pathology and Developing Therapies for Lysosomal Storage Disorders
◊
Gene therapy for lysosomal storage diseases: Current clinical trial prospects